Ad is loading...
AURA
Price
$8.95
Change
-$0.08 (-0.89%)
Updated
Nov 22 closing price
109 days until earnings call
CMPX
Price
$1.49
Change
+$0.11 (+7.97%)
Updated
Nov 22 closing price
116 days until earnings call
Ad is loading...

AURA vs CMPX

Header iconAURA vs CMPX Comparison
Open Charts AURA vs CMPXBanner chart's image
Aura Biosciences
Price$8.95
Change-$0.08 (-0.89%)
Volume$285.88K
CapitalizationN/A
Compass Therapeutics
Price$1.49
Change+$0.11 (+7.97%)
Volume$540.04K
CapitalizationN/A
AURA vs CMPX Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CMPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AURA vs. CMPX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a StrongSell and CMPX is a Hold.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (AURA: $8.95 vs. CMPX: $1.49)
Brand notoriety: AURA and CMPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 139% vs. CMPX: 108%
Market capitalization -- AURA: $447.07M vs. CMPX: $205.01M
AURA [@Biotechnology] is valued at $447.07M. CMPX’s [@Biotechnology] market capitalization is $205.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileCMPX’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • CMPX’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than CMPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 4 TA indicator(s) are bullish while CMPX’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 4 bullish, 6 bearish.
  • CMPX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both AURA and CMPX are a bad buy in the short-term.

Price Growth

AURA (@Biotechnology) experienced а -5.49% price change this week, while CMPX (@Biotechnology) price change was +7.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

AURA is expected to report earnings on Mar 12, 2025.

CMPX is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($447M) has a higher market cap than CMPX($205M). AURA YTD gains are higher at: 1.016 vs. CMPX (-4.487). CMPX has higher annual earnings (EBITDA): -53.58M vs. AURA (-91.84M). AURA has more cash in the bank: 174M vs. CMPX (135M). CMPX has less debt than AURA: CMPX (6.88M) vs AURA (19.1M). CMPX has higher revenues than AURA: CMPX (850K) vs AURA (0).
AURACMPXAURA / CMPX
Capitalization447M205M218%
EBITDA-91.84M-53.58M171%
Gain YTD1.016-4.487-23%
P/E RatioN/AN/A-
Revenue0850K-
Total Cash174M135M129%
Total Debt19.1M6.88M278%
TECHNICAL ANALYSIS
Technical Analysis
AURACMPX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
78%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
70%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
AURA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CMPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VYSVX24.060.41
+1.73%
Vericimetry US Small Cap Value
PHLAX40.230.24
+0.60%
PGIM Jennison Health Sciences A
KTRZX10.060.02
+0.20%
DWS Global Income Builder R6
GEBSX10.18N/A
N/A
Goldman Sachs ESG Em Mkts Eq R6
FUFRX25.92-0.10
-0.38%
Franklin Utilities R6

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with VTYX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then VTYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-0.89%
VTYX - AURA
56%
Loosely correlated
+6.94%
ABCL - AURA
53%
Loosely correlated
+1.47%
EDIT - AURA
52%
Loosely correlated
+2.95%
ABOS - AURA
49%
Loosely correlated
+2.60%
VRDN - AURA
47%
Loosely correlated
+2.96%
More

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with FHTX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
+7.97%
FHTX - CMPX
40%
Loosely correlated
+1.55%
ABCL - CMPX
40%
Loosely correlated
+1.47%
XNCR - CMPX
38%
Loosely correlated
+3.78%
AURA - CMPX
37%
Loosely correlated
-0.89%
ABOS - CMPX
37%
Loosely correlated
+2.60%
More